A study found multiple factors that contributed to invasive melanoma tumor upstaging as well as higher mortality rates among patients with upstaged tumors, one of which is medical management.
According to a study conducted by Amanda Rosenthal, MD, a micrographic surgery and dermatologic oncology fellow at Cedars-Sinai Medical Center and Kaiser Permanente Los Angeles Medical Center, and colleagues, the clinical implication and prognostic outcomes associated with tumor upstaging in invasive melanoma are worse than clinicians previously thought.
“Our study found higher rates of tumor